UniProt/SwissProt ID: | PA2G4_HUMAN |
Description: | proliferation-associated 2G4, 38kDa [Source:HGNC Symbol;Acc:8550] |
Location: | chr12 q13.2 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S2 | EDEQ | HPRD; phosphoELM; SysPTM | |
T366 | SASRKtQKKKK | PRKCB | HPRD |
S361 | ALLQSsASRKT | TraC | PhosphoSitePlus; SysPTM |
T11 | EQQEQtIAEDL | PhosphoSitePlus; HPRD | |
T366 | SASRKtQKKKK | TraC | PhosphoSitePlus |
S360 | KALLQsSASRK | HPRD | |
S44 | SSSGVsVLSLC | Peptidase_M24 | PhosphoSitePlus |
T261 | GLKMKtSRAFF | Peptidase_M24 | PhosphoSitePlus |
Y98 | KSDQDyILKEG | Peptidase_M24 | PhosphoSitePlus |
T386 | ATSGEtLEENE | HPRD; phosphoELM; RegPhos; SysPTM | |
S361 | ALLQSsASRKT | HPRD; phosphoELM; SysPTM | |
Y255 | DPSKQyGLKMK | Peptidase_M24 | PhosphoSitePlus |
S90 | CVCHFsPLKSD | Peptidase_M24 | PhosphoSitePlus |
T60 | MIMEEtGKIFK | Peptidase_M24 | PhosphoSitePlus |
T366 | SASRKtQKKKK | PKCb | RegPhos |
T366 | SASRKtQKKKK | PKCa | RegPhos |
T366 | SASRKtQKKKK | PKCg | RegPhos |
S363 | LQSSAsRKTQK | PKCg | RegPhos |
S363 | LQSSAsRKTQK | PKCa | RegPhos |
S363 | LQSSAsRKTQK | PKCb | RegPhos |
S363 | LQSSAsRKTQK | TraC | PhosphoSitePlus |
S383 | AENATsGETLE | HPRD | |
S360 | KALLQsSASRK | TraC | PhosphoSitePlus |
T386 | ATSGEtLEENE | TraC | PhosphoSitePlus; SysPTM |
T19 | EDLVVtKYKMG | HPRD; SysPTM | |
S335 | PMRITsGPFEP | HPRD | |
S2 | MSGEDeQ | RegPhos; SysPTM | |
T366 | SASRKtQKKKK | PRKCA | HPRD |
T366 | SASRKtQKKKK | PRKCG | HPRD |
S363 | LQSSAsRKTQK | PRKCG | HPRD |
S363 | LQSSAsRKTQK | PRKCA | HPRD |
S363 | LQSSAsRKTQK | PRKCB | HPRD |
S2 | ____MsGEDEQ | PhosphoSitePlus; SysPTM | |
T366 | SASRKtQKKKK | RegPhos | |
Dephosphorylation site |
PA2G4_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000302886 | D394Y | BIOMART | Breast Cancer | 21930507, 21930502 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000302886 | Non-small cell lung carcinoma | Treatment (none vs CIGB-300 treatment) | cell line | Down | 0.5 | 20804217 |
ENSP00000302886 | Breast Cancer | Normal vs. Cancer | tissue | Up | 2.4 | 20005186 |
ENSP00000302886 | Ovarian Cancer | Metastasis | cell line | Up | 17892554 | |
ENSP00000302886 | Biliary Tract Cancer | Metastasis | cell line | Down | 0.33 | 19299076 |
Hyperphosphorylation site |
PA2G4_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
KPCG_HUMAN | PA2G4_HUMAN | kinase -> substrate | HPRD |
ZAGL2_HUMAN | PA2G4_HUMAN | kinase -> substrate | RegPhos |
KPCA_HUMAN | PA2G4_HUMAN | kinase -> substrate | HPRD |
KPCB_HUMAN | PA2G4_HUMAN | kinase -> substrate | HPRD |
Function Annotation |
KEGG Pathway |
PA2G4_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0008283 | cell proliferation | TAS | biological_process |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0009987 | cellular process | IEA | biological_process |
GO:0003700 | sequence-specific DNA binding transcription factor | IDA | molecular_function |
GO:0005737 | cytoplasm | IDA | cellular_component |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0003723 | RNA binding | IEA | molecular_function |
GO:0005730 | nucleolus | IDA | cellular_component |
GO:0045892 | negative regulation of transcription, DNA-dependen | IDA | biological_process |
GO:0006351 | transcription, DNA-dependent | IEA | biological_process |
GO:0006364 | rRNA processing | IEA | biological_process |
GO:0003677 | DNA binding | IDA | molecular_function |
GO:0006417 | regulation of translation | IEA | biological_process |
GO:0031625 | ubiquitin protein ligase binding | IPI | molecular_function |
GO:0007050 | cell cycle arrest | TAS | biological_process |
GO:0030529 | ribonucleoprotein complex | IEA | cellular_component |